3 days AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer Zacks
The FDA’s nod is based on late-stage data, which show AZN’s Datroway cuts the risk of disease progression/death by 37% vs chemotherapy in certain breast cancer patients.
X